| Article Details : |
|
| | | Article Name : | | | Cuidados com o uso de medicamentos para
emagrecimento: revisão bibliográfica | | Author Name : | | | CAREN MARINS PEDROSA
CYBELLE RAYANE CASTRO DO NASCIMENTO
ELAINY NEVES DE LIMA
TIAGO RODRIGUES DUARTE COMAPA, PAULO HENRIQUE FREITAS
| | Publisher : | | | Bridge Center | | Article URL : |  | | | Abstract : | | | Introduction: Obesity is a global problem that affects about 3
billion people, being considered a chronic disease that can cause or
stimulate the development of other types of diseases. Weight loss has
become the main focus of many campaigns in the media, as much as in
society, due to this, the market for appetite-suppressing drugs has been
growing due to the constant search for people for quick weight loss.
Objective: Conduct a bibliographic review about the main
drugs used in the weight loss process and the necessary care for patients
with chronic non-communicable diseases.
Method: This was a systematic bibliographic review based on
the scientific search platforms Scielo (Scientific Electronic Library
Online) and Lilacs (Virtual Health Library), for searching articles
indexed in national journals from 2010 to 2020, as well as dissertations
Masters and Doctoral theses. The keywords formed from the Decs
platform (Health Sciences Descriptors) were: Weight loss, Medicines,
Phytotherapics, Treatment, Adverse effect, Medicines, Phytotherapics,
Treatment, Adverse effect.
Results: Both herbal medicines and industrialized drugs have
a significant effect on weight loss therapy. However, it is necessary to use
them properly and rationally, taking into account the possible side
effects and toxic levels that may arise during the treatment. For this reason, the pharmaceutical professional plays a fundamental role in
monitoring and controlling the dispensing of these drugs.
Conclusion: The most commercialized herbal medicines and
most prescribed by doctors as the first choice for treating obesity are
Camellia Sinensis (green tea), Garcinia Cambogia, Caralluma, and
Cavalinha. Among the industrialized drugs used for this purpose,
sibutramine and Orlistat stand out, the only ones authorized for
commercialization by ANVISA. | | Keywords : | | | Slimming. Weight Loss Drugs. Appetite Suppressants.
Pharmaceutical Care in Obesity. Adverse effect.
|
|
|
|
|
|
|
|
| Announcements
|
- Volume 9, issue 5, August issue - publishing in progress
- Volume 9, Issue 2/ May 2021 publishing IN PROGRESS
- Call for Papers: open. Articles will be uploaded constantly, once the evaluation process is complete.
- The Certificates of Publication can be downloaded from RECEIVED ARTICLES section.
- COVER - VOLUME 2, ISSUE 12 / MARCH 2015
- COVER - VOLUME 3, ISSUE 2 / MAY 2015
- COVER - VOLUME 3, ISSUE 3 / JUNE 2015
- COVER - VOLUME 3, ISSUE 4 / JULY 2015
- COVER - VOLUME 3, ISSUE 8/ NOVEMBER 2015
- COVER - VOLUME 4, ISSUE 4 / JULY 2016
- COVER - VOLUME 4, ISSUE 5 / AUGUST 2016
- COVER - VOLUME 7, ISSUE 11/ FEBRUARY 2020
- Volume 9, issue 3, June 2021 publishing in progress
|
|
|
| New Launched Project |
 |
|
|
| Recommend & Share
|
|